Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients

We report the changed levels of serum amyloid alpha, an immunologically active protein, in Parkinson’s disease (PD) patients’ peripheral tissues. We have previously shown that Saa-1 and -2 (serum amyloid alpha-1,-2, genes) were among the top downregulated genes in PD patients’ skin, using whole-geno...

Full description

Bibliographic Details
Main Authors: Lille Kurvits, Ene Reimann, Liis Kadastik-Eerme, Laura Truu, Külli Kingo, Triin Erm, Sulev Kõks, Pille Taba, Anu Planken
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.00013/full
_version_ 1818493132732366848
author Lille Kurvits
Lille Kurvits
Ene Reimann
Liis Kadastik-Eerme
Laura Truu
Külli Kingo
Külli Kingo
Triin Erm
Sulev Kõks
Sulev Kõks
Pille Taba
Anu Planken
author_facet Lille Kurvits
Lille Kurvits
Ene Reimann
Liis Kadastik-Eerme
Laura Truu
Külli Kingo
Külli Kingo
Triin Erm
Sulev Kõks
Sulev Kõks
Pille Taba
Anu Planken
author_sort Lille Kurvits
collection DOAJ
description We report the changed levels of serum amyloid alpha, an immunologically active protein, in Parkinson’s disease (PD) patients’ peripheral tissues. We have previously shown that Saa-1 and -2 (serum amyloid alpha-1,-2, genes) were among the top downregulated genes in PD patients’ skin, using whole-genome RNA sequencing. In the current study, we characterized the gene and protein expression profiles of skin and blood samples from patients with confirmed PD diagnosis and age/sex matched controls. qRT-PCR analysis of PD skin demonstrated downregulation of Saa-1 and -2 genes in PD patients. However, the lowered amount of protein could not be visualized using immunohistochemistry, due to low quantity of SAA (Serum Amyloid Alpha, protein) in skin. Saa-1 and -2 expression levels in whole blood were below detection threshold based on RNA sequencing, however significantly lowered protein levels of SAA1/2 in PD patients’ serum were shown with ELISA, implying that SAA is secreted into the blood. These results show that SAA is differentially expressed in the peripheral tissues of PD patients.
first_indexed 2024-12-10T17:51:12Z
format Article
id doaj.art-34c10cc9c7524370a09e1faee0ab276e
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-10T17:51:12Z
publishDate 2019-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-34c10cc9c7524370a09e1faee0ab276e2022-12-22T01:39:03ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-01-011310.3389/fnins.2019.00013421012Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease PatientsLille Kurvits0Lille Kurvits1Ene Reimann2Liis Kadastik-Eerme3Laura Truu4Külli Kingo5Külli Kingo6Triin Erm7Sulev Kõks8Sulev Kõks9Pille Taba10Anu Planken11Department of Neurology and Neurosurgery, University of Tartu, Tartu, EstoniaDepartment of Neurology, Charité – Universitätsmedizin Berlin, Berlin, GermanyInstitute of Pathophysiology, University of Tartu, Tartu, EstoniaDepartment of Neurology and Neurosurgery, University of Tartu, Tartu, EstoniaLaboratory of Bioenergetics, National Institute of Chemical Physics and Biophysics, Tallinn, EstoniaDepartment of Dermatology, University of Tartu, Tartu, EstoniaDermatology Clinic, Tartu University Hospital, Tartu, EstoniaDepartment of Pathology, Tartu University Hospital, Tartu, EstoniaCentre for Comparative Genomics, Murdoch University, Perth, WA, AustraliaPerron Institute for Neurological and Translational Science, University of Western Australia, Perth, WA, AustraliaDepartment of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia0Oncology and Haematology Clinic, North-Estonian Medical Centre, Tallinn, EstoniaWe report the changed levels of serum amyloid alpha, an immunologically active protein, in Parkinson’s disease (PD) patients’ peripheral tissues. We have previously shown that Saa-1 and -2 (serum amyloid alpha-1,-2, genes) were among the top downregulated genes in PD patients’ skin, using whole-genome RNA sequencing. In the current study, we characterized the gene and protein expression profiles of skin and blood samples from patients with confirmed PD diagnosis and age/sex matched controls. qRT-PCR analysis of PD skin demonstrated downregulation of Saa-1 and -2 genes in PD patients. However, the lowered amount of protein could not be visualized using immunohistochemistry, due to low quantity of SAA (Serum Amyloid Alpha, protein) in skin. Saa-1 and -2 expression levels in whole blood were below detection threshold based on RNA sequencing, however significantly lowered protein levels of SAA1/2 in PD patients’ serum were shown with ELISA, implying that SAA is secreted into the blood. These results show that SAA is differentially expressed in the peripheral tissues of PD patients.https://www.frontiersin.org/article/10.3389/fnins.2019.00013/fullneurodegenarative diseaseserum amyloid A (SAA)Parkinson’s disease (PD)intrinsically disordered protein (IDP)skin biopsy
spellingShingle Lille Kurvits
Lille Kurvits
Ene Reimann
Liis Kadastik-Eerme
Laura Truu
Külli Kingo
Külli Kingo
Triin Erm
Sulev Kõks
Sulev Kõks
Pille Taba
Anu Planken
Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients
Frontiers in Neuroscience
neurodegenarative disease
serum amyloid A (SAA)
Parkinson’s disease (PD)
intrinsically disordered protein (IDP)
skin biopsy
title Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients
title_full Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients
title_fullStr Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients
title_full_unstemmed Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients
title_short Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients
title_sort serum amyloid alpha is downregulated in peripheral tissues of parkinson s disease patients
topic neurodegenarative disease
serum amyloid A (SAA)
Parkinson’s disease (PD)
intrinsically disordered protein (IDP)
skin biopsy
url https://www.frontiersin.org/article/10.3389/fnins.2019.00013/full
work_keys_str_mv AT lillekurvits serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT lillekurvits serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT enereimann serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT liiskadastikeerme serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT lauratruu serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT kullikingo serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT kullikingo serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT triinerm serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT sulevkoks serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT sulevkoks serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT pilletaba serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients
AT anuplanken serumamyloidalphaisdownregulatedinperipheraltissuesofparkinsonsdiseasepatients